8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Moderna Appoints Juan Andres as COO as Oncology Pipeline Expands
Filed with the SEC on · Summarized by InvestorsBot
Moderna is creating a chief operating officer role and will appoint former executive Juan Andres to the position effective October 5, 2026, reporting to CEO Stéphane Bancel and overseeing manufacturing. Chief Technical Operations and Quality Officer Jerh Collins will retire after four years, as Moderna prepares for the potential launch of intismeran autogene, jointly developed with Merck, and advances its oncology and infectious disease businesses.